Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Renews GMP certifications for India and Malaysia sites
Approval based on CAPItello-291 results which showed this combination reduced the risk of disease progression or death by 50% vs. Faslodex alone in a biomarker-altered population
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine
Subscribe To Our Newsletter & Stay Updated
